Top

Published in:

01-12-2010 | Advances and Challenges in PKU

Therapeutic liver repopulation for phenylketonuria

Authors: Cary O. Harding, K. M. Gibson

Published in: Journal of Inherited Metabolic Disease | Issue 6/2010

Abstract

Problems with long-term dietary compliance in phenylketonuria (PKU) necessitate the development of alternative treatment approaches. Therapeutic liver repopulation with phenylalanine hydroxylase (PAH)-expressing cells following hepatocyte or haematopoietic stem cell transplantation has been investigated as a possible novel treatment approach for PKU. Successful therapeutic liver repopulation requires both a stimulus for liver regeneration at the time of cell transplantation and a selective growth advantage for the PAH+ donor cells. Unfortunately, wild-type PAH+ hepatocytes do not enjoy any growth advantage over PAH− cells. Successful correction of hyperphenylalaninemia following therapeutic liver repopulation has been accomplished only in an animal model that yields a selective advantage for the donor cells. Haematopoietic stem cell (HSC)-mediated therapeutic liver repopulation has not been reported in any hyperphenylalaninemic system, and the success of HSC-mediated liver repopulation for PKU may be limited by the slow kinetics of this approach. If therapeutic liver repopulation is to be employed successfully in humans with PKU, an effective method of providing a selective growth advantage for the donor cells must be developed. If this can be achieved, liver repopulation with 10–20% wild-type hepatocytes will likely completely normalize Phe clearance in individuals with PKU.

Abkowitz JL, Sabo KM, Yang Z, Vite CH, Shields LE, Haskins ME (2009) In utero transplantation of monocytic cells in cats with alpha-mannosidosis. Transplantation 88:323–329CrossRefPubMed

Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R (2004) The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant 13:765–773CrossRefPubMed

Au WY, So JC, Ma SK, Lie AK (2009) Glucose-6-phosphate-dehydrogenase deficiency and haematopoietic stem cell transplantation in Chinese patients. Hong Kong Med J 15(Suppl 3):35–38PubMed

Aytekin C, Yuksek M, Dogu F, Yagmurlu A, Yildiran A, Fitoz S, Kologlu M, Babacan E, Hershfield MS, Ikinciogullari A (2008) An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication. Pediatr Transplant 12:479–482CrossRefPubMed

Barfield RC, Kasow KA, Hale GA (2008) Advances in pediatric hematopoietic stem cell transplantation. Cancer Biol Ther 7:1533–1539PubMed

Burlina AB (2004) Hepatocyte transplantation for inborn errors of metabolism. J Inherit Metab Dis 27:373–383CrossRefPubMed

Cartier N, Aubourg P (2008) Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr Opin Mol Ther 10:471–478PubMed

Christensen HN (1982) Interorgan amino acid nutrition. Physiol Rev 62:1193–1233PubMed

Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, Arya R, Wade JJ, Verma A, Heaton ND, Rela M, Mieli-Vergani G (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78:1812–1814CrossRefPubMed

Di Campli C, Gasbarrini G, Gasbarrini A (2003) Review article: a medicine based on cell transplantation-is there a future for treating liver diseases? Aliment Pharmacol Ther 18:473–480CrossRefPubMed

Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137:466–481CrossRefPubMed

Enns GM, Millan MT (2008) Cell-based therapies for metabolic liver disease. Mol Genet Metab 95:3–10CrossRefPubMed

Enquist IB, Nilsson E, Mansson JE, Ehinger M, Richter J, Karlsson S (2009) Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease. Stem Cells 27:744–752CrossRefPubMed

Faraci M, Morreale G, Boeri E, Lanino E, Dallorso S, Dini G, Scuderi F, Cohen A, Cappelli B (2008) Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria. Pediatr Transplant 12:117–120CrossRefPubMed

Fitzpatrick AS, Loughrey CM, Johnston P, McKee S, Spence W, Flynn P, Jones FG, Morrow JI (2008) Haematopoietic stem-cell transplant for adult cerebral adrenoleukodystrophy. Eur J Neurol 15:e21–e22CrossRefPubMed

Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422–1426CrossRefPubMed

Grompe M, Lindstedt S, al-Dhalimy M, Kennaway NG, Papaconstantinou J, Torres-Ramos CA, Ou CN, Finegold M (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nature Genetics 10:453–460CrossRefPubMed

Guha C, Parashar B, Deb NJ, Garg M, Gorla GR, Singh A, Roy-Chowdhury N, Vikram B, Roy-Chowdhury J (2002) Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36:354–362CrossRefPubMed

Hamman K, Clark H, Montini E, Al-Dhalimy M, Grompe M, Finegold M, Harding CO (2005) Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria. Mol Ther 12:337–344CrossRefPubMed

Hansen K, Horslen S (2008) Metabolic liver disease in children. Liver Transpl 14:713–733CrossRefPubMed

Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2:709–712CrossRefPubMed

Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262–1267CrossRefPubMed

Irani AN, Malhi H, Slehria S, Gorla GR, Volenberg I, Schilsky ML, Gupta S (2001) Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol Ther 3:302–309CrossRefPubMed

Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N (2008) Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1. Transplantation 85:1253–1260CrossRefPubMed

Joseph B, Kapoor S, Schilsky ML, Gupta S (2009) Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model. Hepatology 49:1616–1624CrossRefPubMed

Kocken JM, Borel Rinkes IH, Bijma AM, de Roos WK, Bouwman E, Terpstra OT, Sinaasappel M (1996) Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation 62:358–364CrossRefPubMed

Laconi E, Laconi S (2002) Principles of hepatocyte repopulation. Semin Cell Dev Biol 13:433–438CrossRefPubMed

Lee B, Dennis JA, Healy PJ, Mull B, Pastore L, Yu H, Aguilar-Cordova E, O'Brien W, Reeds P, Beaudet AL (1999) Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia. Proc Natl Acad Sci USA 96:3981–3986CrossRefPubMed

Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK (2007) Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 16:629–637PubMed

Lim ZY, Ho AY, Abrahams S, Fensom A, Aldouri M, Pagliuca A, Shaw C, Mufti GJ (2008) Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease. Bone Marrow Transplant 41:831–832CrossRefPubMed

Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM (2008) Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol 14:3464–3470CrossRefPubMed

Malm G, Gustafsson B, Berglund G, Lindstrom M, Naess K, Borgstrom B, von Dobeln U, Ringden O (2008) Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Acta Paediatr 97:1108–1112CrossRefPubMed

Matas AJ, Sutherland DE, Steffes MW, Mauer SM, Sowe A, Simmons RL, Najarian JS (1976) Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 192:892–894CrossRefPubMed

Meyburg J, Alexandrova K, Barthold M, Kafert-Kasting S, Schneider AS, Attaran M, Hoerster F, Schmidt J, Hoffmann GF, Ott M (2009) Liver cell transplantation: basic investigations for safe application in infants and small children. Cell Transplant 18:777–786CrossRefPubMed

Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, Meroni M, Giron G, Burlina AB (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317–318CrossRefPubMed

Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou CN, Finegold M, Grompe M (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genet 12:266–273CrossRefPubMed

Park SM, Vo K, Lallier M, Cloutier AS, Brochu P, Alvarez F, Martin SR (2006) Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease. Cell Transplant 15:13–22CrossRefPubMed

Polgreen LE, Tolar J, Plog M, Himes JH, Orchard PJ, Whitley CB, Miller BS, Petryk A (2008) Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant 41:1005–1011CrossRefPubMed

Prasad VK, Kurtzberg J (2008) Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 41:99–108CrossRefPubMed

Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G, Karani J, Champion MP, Heaton N, Mohamed R, Dhawan A (2008) Hepatocyte transplantation followed by auxiliary liver transplantation-a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 8:452–457CrossRefPubMed

Ramsubir S, Nonaka T, Girbes CB, Carpentier S, Levade T, Medin JA (2008) In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease. Mol Genet Metab 95:133–141CrossRefPubMed

Reyes J, Rubenstein W, Mieles L, Strom SC, Tobin R, Trucco M (1996) The use of cultured hepatocyte infusion via the portal vein for the treatment of ornithine transcarbamoylase deficiency by transplantation of enzymatically competent ABO/Rh-matched cells. Hepatology 24:308ACrossRef

Rovelli AM (2008) The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update. Bone Marrow Transplant 41(Suppl 2):S87–S89CrossRefPubMed

Sauer M, Meissner B, Fuchs D, Gruhn B, Kabisch H, Erttmann R, Suttorp M, Beilken A, Luecke T, Welte K, Grigull L, Sykora KW (2009) Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. Bone Marrow Transplant 43:375–381CrossRefPubMed

Shi Z, Liang XL, Lu BX, Pan SY, Chen X, Tang QQ, Wang Y, Huang F (2005) Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation. World J Gastroenterol 11:3691–3695PubMed

Skvorak KJ, Paul HS, Dorko K, Marongiu F, Ellis E, Chace D, Ferguson C, Gibson KM, Homanics GE, Strom SC (2009a) Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther 17:1266–1273CrossRefPubMed

Skvorak KJ, Hager EJ, Arning E, Bottiglieri T, Paul HS, Strom SC, Homanics GE, Sun Q, Jansen EE, Jakobs C, Zinnanti WJ, Gibson KM (2009b) Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta 1792:1004–1010PubMed

Smets F, Najimi M, Sokal EM (2008) Cell transplantation in the treatment of liver diseases. Pediatr Transplant 12:6–13CrossRefPubMed

Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76:735–738CrossRefPubMed

Somaraju UR, Tadepalli K (2008) Hematopoietic stem cell transplantation for Gaucher disease. Cochrane Database Syst Rev, CD006974

Syres K, Harrison F, Tadlock M, Jester JV, Simpson J, Roy S, Salomon DR, Cherqui S (2009) Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 114:2542–2552CrossRefPubMed

Tolar J, Petryk A, Khan K, Bjoraker KJ, Jessurun J, Dolan M, Kivisto T, Charnas L, Shapiro EG, Orchard PJ (2009) Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant 43:21–27CrossRefPubMed

Vajro P, Strisciuglio P, Houssin D, Huault G, Laurent J, Alvarez F, Bernard O (1993) Correction of phenylketonuria after liver transplantation in a child with cirrhosis. N Engl J Med 329:363CrossRefPubMed

Waelzlein JH, Puppi J, Dhawan A (2009) Hepatocyte transplantation for correction of inborn errors of metabolism. Curr Opin Nephrol Hypertens 18:481–488CrossRefPubMed

Weber A, Groyer-Picard MT, Franco D, Dagher I (2009) Hepatocyte transplantation in animal models. Liver Transpl 15:7–14CrossRefPubMed

Wiederkehr JC, Kondos GT, Pollak R (1990) Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 50:466–471CrossRefPubMed

Wynn RF, Mercer J, Page J, Carr TF, Jones S, Wraith JE (2009a) Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients. J Pediatr 154:135–139CrossRefPubMed

Wynn RF, Wraith JE, Mercer J, O'Meara A, Tylee K, Thornley M, Church HJ, Bigger BW (2009b) Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr 154:609–611CrossRefPubMed

Title: Therapeutic liver repopulation for phenylketonuria
Authors: Cary O. Harding
K. M. Gibson
Publication date: 01-12-2010
Publisher: Springer Netherlands
Published in: Journal of Inherited Metabolic Disease / Issue 6/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-010-9099-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Therapeutic liver repopulation for phenylketonuria

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2010

Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis

Erratum to: Abstract 332-P

Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism

Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience

Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values

SSIEM reflections 2004–2010: the growing stature of our society

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page